WANY
BIO icon

Wealthspire Advisors (New York)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Wealthspire Advisors (New York)’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-70
Closed -$19.6K – 1247
2025
Q3 		$19.6K Buy
+70
New +$19K ﹤0.01% 1694

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wealthspire Advisors (New York)'s BIO Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 70 shares — an estimated $19.6K sold.

Wealthspire Advisors (New York) first reported a position in BIO in Q3 2025 and held it in 1 quarter. The position peaked at $19.6K in Q3 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 70 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $19.6K.
  • Wealthspire Advisors (New York) first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Bio-Rad Laboratories Class A position peaked at $19.6K in Q3 2025.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.